美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06667 美因基因

18.040

+0.020

+0.11%

最高--	最低--	成交量39.69万
今开--	昨收18.020	日振幅1.66%
总市值43.16亿	流通市值43.16亿	总股本2.39亿
成交额714.86万	换手率0.17%	流通股本2.39亿
市净率5.29	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

Data provider: Ningxia XSRK Technology Limited

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"market":"HK","stockBase":{"symbol":"06667","market":"HK","secType":"STK","nameCN":"美因基因","latestPrice":18.04,"timestamp":1656058087023,"preClose":18.02,"halted":0,"volume":396900,"delay":0,"change":0.02,"changeRate":0.00111,"floatShares":239233800,"shares":239233800,"eps":0,"lyrEps":0,"pbRate":5.29,"psRate":15.49,"amount":7148598,"amplitude":0.016648,"volumeRatio":0.13478452814032882,"dividePrice":0,"prevYearClose":18,"fiveDayClose":18,"twentyDayClose":18},"adData":{"groupTypeList":[],"userSplitList":[]},"requestUrl":"/m/hq/s/06667","defaultTab":"news","newsList":[{"id":"2245215154","title":"【新股IPO】美因基因(06667)首挂收报18元 平招股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2245215154","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2245215154?lang=zh_CN&edition=full","pubTime":"2022-06-22 16:20","pubTimestamp":1655886044,"startTime":"0","endTime":"0","summary":"美因基因(06667)首挂收报18元，平招股价，全日成交385.88万股，成交额7424.46万元，最新市值43.06亿元。每手200股，账面亏损手续费。该股早盘开报19.48元，较招股价高8.22%，最低价即为收盘价，而全日最高价为21元，若高位入场，每手将蚀600元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=f68c6d0161a27491a0a2ea84c08bde53","is_publish_highlight":false},{"id":"2245964642","title":"美因基因(6667.HK)首日上市半日收涨3.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245964642","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2245964642?lang=zh_CN&edition=full","pubTime":"2022-06-22 12:04","pubTimestamp":1655870697,"startTime":"0","endTime":"0","summary":"格隆汇6月22日丨美因基因(6667.HK)今日首日上市，盘初一度冲高涨超16%报21港元，半日收涨3.33%报18.6港元，成交5971万港元，最新市值44.5亿港元。　　美因基因是中国最大的消费级基因检测及癌症筛查基因检测平台。2019-2021年，公司分别产生总收入人民币1.24亿元、2.03亿元及2.37亿元。同期录得净利润分别为人民币0.3亿元、0.79亿元及0.79亿元，以及毛利润分别为0.78亿元、1.46亿元及1.67亿元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hk.jrj.com.cn/2022/06/22120436749096.shtml","is_publish_highlight":false},{"id":"1150096405","title":"美因基因正式登陆港交所，为中国最大的消费级基因检测平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1150096405","media":"独角兽早知道","top":-1,"share":"https://www.laohu8.com/m/news/1150096405?lang=zh_CN&edition=full","pubTime":"2022-06-22 10:19","pubTimestamp":1655864351,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/4e513675f68a3a56ffa08f515468cb1d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4e513675f68a3a56ffa08f515468cb1d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2245218436","title":"港股开盘：恒生指数跌0.42％，美因基因上市涨8.22％","url":"https://stock-news.laohu8.com/highlight/detail?id=2245218436","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2245218436?lang=zh_CN&edition=full","pubTime":"2022-06-22 09:24","pubTimestamp":1655861071,"startTime":"0","endTime":"0","summary":"今日香港恒生指数开盘跌0.42％，报21469.74点，国企指数跌0.56％，报7507.67点，红筹指数跌0.14％，报3796.26点，恒生科技指数跌0.48％，报4737.49点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hk.jrj.com.cn/2022/06/22092436748474.shtml","is_publish_highlight":false},{"id":"2245267872","title":"《新股表现》美因基因(06667.HK)高开8.2%报19.48元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245267872","media":"AAFN","top":-1,"share":"https://www.laohu8.com/m/news/2245267872?lang=zh_CN&edition=full","pubTime":"2022-06-22 09:23","pubTimestamp":1655861001,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1192180&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_publish_highlight":false},{"id":"2245026221","title":"新股首日 | 美因基因(06667)首日挂牌 早盘高开逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245026221","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2245026221?lang=zh_CN&edition=full","pubTime":"2022-06-22 09:22","pubTimestamp":1655860933,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美因基因(06667)首日挂牌，公告显示，公司发行1196.18万股股份，每股定价18港元，每手200股，所得款项净额约为1.53亿港元。截至发稿，美因基因涨8.22%，报19.48港元，成交额1308.26万港元。据悉，美因基因是中国领先的基因检测平台公司，专注于消费级基因检测及癌症筛查服务，根据弗若斯特沙利文的资料，公司为中国最大的消费级基因检测平台，按2020年已进行检测数量计，公司的市场份额超过60%；按同年收入计，公司的市场份额则为34.2%，在中国排名第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/742477.html","is_publish_highlight":false},{"id":"1103873938","title":"港股开盘 | 恒指低开0.42%，美因基因首挂高开逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103873938","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1103873938?lang=zh_CN&edition=full","pubTime":"2022-06-22 09:20","pubTimestamp":1655860819,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2245239640","title":"港股美因基因暗盘收涨8.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245239640","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2245239640?lang=zh_CN&edition=full","pubTime":"2022-06-21 18:54","pubTimestamp":1655808878,"startTime":"0","endTime":"0","summary":"美因基因将于明日正式于港交所上市，今日暗盘收涨8.56%，报19.54港元，发行价18港元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hk.jrj.com.cn/2022/06/21185436747232.shtml","is_publish_highlight":false},{"id":"2245828178","title":"新股暗盘 | 美因基因(06667)暗盘盘初涨超8% 每手赚308港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245828178","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2245828178?lang=zh_CN&edition=full","pubTime":"2022-06-21 18:45","pubTimestamp":1655808323,"startTime":"0","endTime":"0","summary":"美因基因(06667)将于6月22日（星期三）在香港挂牌。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20220621/20220621184539_57852.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20220621/20220621184539_57852.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/742198.html","is_publish_highlight":false},{"id":"2245284864","title":"美因基因暗盘收涨8.56% 一手赚308港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245284864","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2245284864?lang=zh_CN&edition=full","pubTime":"2022-06-21 18:43","pubTimestamp":1655808180,"startTime":"0","endTime":"0","summary":"美因基因将于明日正式于港交所上市，今日暗盘收涨8.56%，报19.54港元，发行价18港元/股，一手赚308港元。　　美因基因公布配发结果，此次IPO全球发售1196.18万股，发售价已厘定为每股发售股份18港元，经扣除公司就全球发售应支付的包销费用、佣金以及估计开支并假设超额配股权完全未获行使，公司将取得全球发售所得款项净额估计约为1.53亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2022-06-21/doc-imizmscu8001635.shtml?finpagefr=p_115","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2022-06-21/doc-imizmscu8001635.shtml?finpagefr=p_115","is_publish_highlight":false},{"id":"2245928163","title":"《新股表现》美因基因(06667.HK)暗盘收报19.54元  高上市价8.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245928163","media":"AAFN","top":-1,"share":"https://www.laohu8.com/m/news/2245928163?lang=zh_CN&edition=full","pubTime":"2022-06-21 18:33","pubTimestamp":1655807589,"startTime":"0","endTime":"0","summary":"根据辉立交易平台显示，明天挂牌的美因基因暗盘高开2.8%报18.5元获承接，最高见21.6元，收报19.54元，较上市价18元，高8.6%或1.54元，成交34.4万股，涉资671万元。不计手续费，每手200股，账面赚308元。美因是内地领先的基因检测平台公司，专注於消费级基因检测及癌症筛查服务。上市独家保荐人中信建投国际。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1192093&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_publish_highlight":false},{"id":"2245238618","title":"《新股表现》美因基因(06667.HK)暗盘收报19.54元 高上市价8.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245238618","media":"阿思达克财经新闻","top":-1,"share":"https://www.laohu8.com/m/news/2245238618?lang=zh_CN&edition=full","pubTime":"2022-06-21 18:33","pubTimestamp":1655807580,"startTime":"0","endTime":"0","summary":"根据辉立交易平台显示，明天挂牌的美因基因暗盘高开2.8%报18.5元获承接，最高见21.6元，收报19.54元，较上市价18元，高8.6%或1.54元，成交34.4万股，涉资671万元。不计手续费，每手200股，账面赚308元。美因是内地领先的基因检测平台公司，专注于消费级基因检测及癌症筛查服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062119385181fd62c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062119385181fd62c1&s=b","is_publish_highlight":false},{"id":"2245288130","title":"新股暗盘 | 美因基因(6667.HK)暗盘段大涨20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245288130","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2245288130?lang=zh_CN&edition=full","pubTime":"2022-06-21 16:20","pubTimestamp":1655799613,"startTime":"0","endTime":"0","summary":"格隆汇6月21日丨据富途证券，美因基因(6667.HK)暗盘段现报21.6港元，较发行价18港元大涨20%，总市值51.67亿港元。公司是中国领先的基因检测平台，2019年至2021年收益分别为1.23亿、2.03亿、2.37亿元人民币，净利分别为2969.1万、7909.7万、7901.5万元人民币，每股有形资产净值4.29 - 4.48港元，2021历史市盈率46.51 - 57.33倍。此次上市发售1196.18万股，其中香港发售119.62万股，国际发售1076.56万股，每手200股，香港公开发售获9.62倍认购，净筹约1.534亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062116201884585945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062116201884585945&s=b","is_publish_highlight":false},{"id":"2245002494","title":"《新股表现》美因基因(06667.HK)暗盘高开2.8%报18.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245002494","media":"AAFN","top":-1,"share":"https://www.laohu8.com/m/news/2245002494?lang=zh_CN&edition=full","pubTime":"2022-06-21 16:18","pubTimestamp":1655799512,"startTime":"0","endTime":"0","summary":"根据辉立交易平台显示，明天挂牌的美因基因暗盘高开2.8%报18.5元获承接，现报21.2元，较上市价18元，高近18%，成交4.7万股。美因是内地领先的基因检测平台公司，专注於消费级基因检测及癌症筛查服务。上市独家保荐人中信建投国际。~阿思达克财经新闻网址: www.aastocks.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1192050&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_publish_highlight":false},{"id":"1164699201","title":"老虎暗盘 | 美因基因涨超5%，此前获9.62倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1164699201","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1164699201?lang=zh_CN&edition=full","pubTime":"2022-06-21 16:15","pubTimestamp":1655799336,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2245828815","title":"6月21日，美因基因(06667.HK)配售结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2245828815","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2245828815?lang=zh_CN&edition=full","pubTime":"2022-06-21 15:10","pubTimestamp":1655795445,"startTime":"0","endTime":"0","summary":"6月21日，美因基因配售结束。配售招股价18-22港元，最终定价18港元，每手3600港元。以上内容由证券之星根据公开信息整理，如有问题请联系我们。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062115314681fd37ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022062115314681fd37ef&s=b","is_publish_highlight":false},{"id":"2245404213","title":"配售结果 | 美因基因(06667)一手中签率10.01% 最终定价18港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2245404213","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2245404213?lang=zh_CN&edition=full","pubTime":"2022-06-21 15:01","pubTimestamp":1655794916,"startTime":"0","endTime":"0","summary":"6月21日，美因基因(06667)配售结束。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20220621/20220621150215_62750.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20220621/20220621150215_62750.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/741905.html","is_publish_highlight":false},{"id":"2245073471","title":"《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价 一手中签率仅10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245073471","media":"阿思达克财经新闻","top":-1,"share":"https://www.laohu8.com/m/news/2245073471?lang=zh_CN&edition=full","pubTime":"2022-06-21 08:55","pubTimestamp":1655772927,"startTime":"0","endTime":"0","summary":"美因基因公布招股结果，每股发售价定为18元，为招股价范围的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将于明日挂牌。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成后公司已发行股本约4.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220621085527804b62a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220621085527804b62a5&s=b","is_publish_highlight":false},{"id":"1146987474","title":"美因基因一手中签率10.01%，认购20手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1146987474","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1146987474?lang=zh_CN&edition=full","pubTime":"2022-06-21 08:50","pubTimestamp":1655772631,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","source_url":"","is_publish_highlight":true},{"id":"2245476311","title":"《新股消息》美因基因(06667.HK)公开发售超购8.6倍及下限18元定价 一手中签率仅10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2245476311","media":"AAFN","top":-1,"share":"https://www.laohu8.com/m/news/2245476311?lang=zh_CN&edition=full","pubTime":"2022-06-21 08:41","pubTimestamp":1655772113,"startTime":"0","endTime":"0","summary":"美因基因公布招股结果，每股发售价定为18元，为招股价范围的下限定价，香港公开发售部分录得超额认购约8.62倍。每手200股计，一手中签率10.01%，要认购20手即4,000股才稳获一手。该股将於明日挂牌。基石投资者南昌金融、南昌工控园区及迈克生物合共认购公司969.28万股，占紧随全球发售完成後公司已发行股本约4.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1191853&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0022},{"period":"ytd","weight":0.0022}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0767},{"period":"3month","weight":0.0147},{"period":"6month","weight":-0.0648},{"period":"1year","weight":-0.248},{"period":"ytd","weight":-0.0717}],"name":"美因基因","description":"美因基因有限公司是一家主要从事基因检测的中国控股公司。该公司通过三个部门开展其业务。消费级基因检测服务部门提供营养与代谢检测、癌症风险评估、慢性疾病易感性、药物遗传学检测及传染病检测。癌症筛查服务部门提供Septin9结直肠癌筛查检测、黏结蛋白聚糖2（SDC2）结直肠癌筛查检测及基因环指蛋白180（RNF180）/Septin9胃癌筛查检测。其他服务部门主要向第三方研究机构提供基因研究与分析服务。","exchange":"SEHK","nameEN":"MEGA GENOMICS","compareStock":{"symbol":"HSI","name":"恒生指数"}},"isWeiXinMini":false,"pagemeta":{"title":"美因基因(06667)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美因基因(06667)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美因基因,06667,美因基因股票,美因基因股票老虎,美因基因股票老虎国际,美因基因行情,美因基因股票行情,美因基因股价,美因基因股市,美因基因股票价格,美因基因股票交易,美因基因股票购买,美因基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情"}}